Elevance Health (ELV) to Release Earnings on Tuesday

Key Points

• Elevance Health is set to release its Q3 2025 earnings on October 21st, with analysts expecting earnings of $5.03 per share and revenue of $49.26 billion.
• The company reported a 14.3% increase in revenue year-over-year during its last quarterly report, generating $49.42 billion in revenue despite missing EPS estimates.
• Insiders have been active, with CEO Gail Boudreaux purchasing 8,500 shares recently, increasing her ownership stake in Elevance Health.

Elevance Health (NYSE:ELV - Get Free Report) is expected to be issuing its Q3 2025 results before the market opens on Tuesday, October 21st. Analysts expect Elevance Health to post earnings of $5.03 per share and revenue of $49.2626 billion for the quarter. Individuals are encouraged to explore the company's upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Tuesday, October 21, 2025 at 8:30 AM ET.

Elevance Health (NYSE:ELV - Get Free Report) last posted its quarterly earnings results on Thursday, July 17th. The company reported $8.84 EPS for the quarter, missing analysts' consensus estimates of $9.30 by ($0.46). The company had revenue of $49.42 billion during the quarter, compared to analyst estimates of $48.26 billion. Elevance Health had a net margin of 2.83% and a return on equity of 17.59%. The firm's revenue for the quarter was up 14.3% compared to the same quarter last year. During the same period last year, the firm earned $10.12 EPS. On average, analysts expect Elevance Health to post $34 EPS for the current fiscal year and $39 EPS for the next fiscal year.

Elevance Health Trading Down 0.5%

Shares of Elevance Health stock opened at $351.43 on Tuesday. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.64. Elevance Health has a 12-month low of $273.71 and a 12-month high of $510.24. The company has a market capitalization of $79.14 billion, a price-to-earnings ratio of 14.95, a PEG ratio of 1.29 and a beta of 0.59. The firm's 50-day moving average price is $316.63 and its two-hundred day moving average price is $357.61.

Elevance Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Wednesday, September 10th were given a dividend of $1.71 per share. The ex-dividend date was Wednesday, September 10th. This represents a $6.84 annualized dividend and a dividend yield of 1.9%. Elevance Health's dividend payout ratio (DPR) is currently 29.11%.

Insider Activity

In other news, CEO Gail Boudreaux purchased 8,500 shares of Elevance Health stock in a transaction dated Friday, July 18th. The shares were bought at an average cost of $286.94 per share, for a total transaction of $2,438,990.00. Following the completion of the acquisition, the chief executive officer owned 151,020 shares in the company, valued at approximately $43,333,678.80. This trade represents a 5.96% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Susan D. Devore acquired 1,200 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was acquired at an average price of $312.15 per share, with a total value of $374,580.00. Following the acquisition, the director owned 3,502 shares in the company, valued at $1,093,149.30. The trade was a 52.13% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.29% of the company's stock.

Institutional Trading of Elevance Health

Several institutional investors have recently modified their holdings of ELV. State of Wyoming acquired a new stake in Elevance Health in the second quarter valued at $127,000. Transamerica Financial Advisors LLC increased its stake in shares of Elevance Health by 43.9% in the second quarter. Transamerica Financial Advisors LLC now owns 616 shares of the company's stock valued at $239,000 after buying an additional 188 shares during the period. MUFG Securities EMEA plc acquired a new stake in shares of Elevance Health in the second quarter valued at about $260,000. Kestra Investment Management LLC raised its position in shares of Elevance Health by 20.8% during the second quarter. Kestra Investment Management LLC now owns 709 shares of the company's stock worth $276,000 after acquiring an additional 122 shares during the last quarter. Finally, Occudo Quantitative Strategies LP acquired a new position in shares of Elevance Health in the second quarter worth approximately $363,000. Institutional investors own 89.24% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Weiss Ratings upgraded shares of Elevance Health from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Wednesday, October 8th. Guggenheim boosted their price target on Elevance Health from $360.00 to $398.00 and gave the stock a "buy" rating in a report on Wednesday, October 8th. Leerink Partnrs lowered Elevance Health from a "strong-buy" rating to a "hold" rating in a research note on Thursday, July 17th. Argus reiterated a "hold" rating on shares of Elevance Health in a research report on Monday, July 21st. Finally, Robert W. Baird dropped their target price on shares of Elevance Health from $492.00 to $297.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Twelve analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $412.00.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.